• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仅在无风湿性多肌痛的巨细胞动脉炎患者中,大血管血管炎是复发的一个危险因素。

Large vessel vasculitis is a risk factor for relapse only in giant cell arteritis patients without polymyalgia rheumatica.

作者信息

Moreel Lien, Betrains Albrecht, Boeckxstaens Lennert, Molenberghs Geert, Van Laere Koen, De Langhe Ellen, Vanderschueren Steven, Blockmans Daniel

机构信息

Department of General Internal Medicine, UZ Leuven, Leuven, Belgium.

Department of Microbiology, Immunology, and Transplantation, KU Leuven, Leuven, Belgium.

出版信息

Rheumatology (Oxford). 2025 Apr 1;64(4):2068-2076. doi: 10.1093/rheumatology/keae456.

DOI:10.1093/rheumatology/keae456
PMID:39173669
Abstract

OBJECTIVES

To evaluate differences in presentation and outcome of GCA patients with and without large vessel vasculitis (LVV) and according to the extent and severity of LVV.

METHODS

Consecutive patients diagnosed with GCA between 2003 and 2020 who have had FDG PET imaging at diagnosis ≤3 days after initiation of glucocorticoids (GC) and followed for ≥12 months at the University Hospitals Leuven (Belgium) were included retrospectively. PET scans were visually scored (0-3) in seven vascular areas and a total vascular score (TVS) was calculated. LVV was defined as FDG uptake ≥2 in any large vessel.

RESULTS

We included 238 GCA patients, of which 169 (71%) had LVV. LVV patients were younger (69 vs 74 years, P < 0.001) and more frequently female (72% vs 49%, P = 0.001). In patients without PMR symptoms, the presence of LVV was associated with relapse (aOR 3.05 [95% CI 1.32-7.43], P = 0.011) and with a lower probability of stopping GC (aHR 0.59 [95% CI 0.37-0.94], P = 0.025). However, in those with PMR symptoms, there was no difference in relapse risk (aOR 1.20 [95% CI 0.53-2.66], P = 0.657) and in the probability of stopping GC (aHR 1.25 [95% CI 0.75-2.09], P = 0.394) between patients with and without LVV. A higher TVS was associated with an increased risk of relapse (aOR 1.09 [95% CI 1.04-1.15], P = 0.001) in patients without PMR symptoms, but not in those with PMR symptoms (aOR 1.01 [95% CI 0.96-1.07], P = 0.693).

CONCLUSION

LVV is a risk factor for relapse in GCA patients without PMR symptoms with a higher relapse risk in those with higher TVS.

摘要

目的

评估合并和不合并大血管血管炎(LVV)的巨细胞动脉炎(GCA)患者在临床表现和预后方面的差异,并根据LVV的范围和严重程度进行评估。

方法

回顾性纳入2003年至2020年间在比利时鲁汶大学医院确诊为GCA且在开始使用糖皮质激素(GC)后≤3天内进行了氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)成像且随访≥12个月的连续患者。对PET扫描的七个血管区域进行视觉评分(0 - 3分),并计算总血管评分(TVS)。LVV定义为任何大血管中FDG摄取≥2。

结果

我们纳入了238例GCA患者,其中169例(71%)合并LVV。合并LVV的患者更年轻(69岁对74岁,P < 0.001),女性比例更高(72%对49%,P = 0.001)。在没有风湿性多肌痛(PMR)症状的患者中,LVV的存在与复发相关(调整后比值比[aOR] 3.05 [95%置信区间(CI)1.32 - 7.43],P = 0.011),且停用GC的概率较低(调整后风险比[aHR] 0.59 [95% CI 0.37 - 0.94],P = 0.025)。然而,在有PMR症状的患者中,合并和不合并LVV的患者在复发风险(aOR 1.20 [95% CI 0.53 - 2.66],P = 0.657)和停用GC的概率(aHR 1.25 [95% CI 0.75 - 2.09],P = 0.394)方面没有差异。在没有PMR症状的患者中,较高的TVS与复发风险增加相关(aOR 1.09 [95% CI 1.04 - 1.15],P = 0.001),但在有PMR症状的患者中并非如此(aOR 1.01 [95% CI 0.96 - 1.07],P = 0.693)。

结论

LVV是没有PMR症状的GCA患者复发的危险因素,TVS较高的患者复发风险更高。

相似文献

1
Large vessel vasculitis is a risk factor for relapse only in giant cell arteritis patients without polymyalgia rheumatica.仅在无风湿性多肌痛的巨细胞动脉炎患者中,大血管血管炎是复发的一个危险因素。
Rheumatology (Oxford). 2025 Apr 1;64(4):2068-2076. doi: 10.1093/rheumatology/keae456.
2
Role of F-FDG PET/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica.F-FDG PET/CT在大血管血管炎和风湿性多肌痛中的作用。
J Nucl Med. 2023 Apr;64(4):515-521. doi: 10.2967/jnumed.122.265016.
3
Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study.巨细胞动脉炎中,风湿性多肌痛是疾病更难治疗的一个风险因素:一项回顾性队列研究。
Semin Arthritis Rheum. 2024 Oct;68:152499. doi: 10.1016/j.semarthrit.2024.152499. Epub 2024 Jun 28.
4
HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.巨细胞动脉炎中的 HLA-B52 等位基因可能预示着弥漫性大血管血管炎的形成:一项回顾性研究。
Arthritis Res Ther. 2021 Sep 13;23(1):238. doi: 10.1186/s13075-021-02618-4.
5
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin.他汀类药物是否降低大血管血管炎高危患者的血管炎症?多肌痛、巨细胞动脉炎和不明原因发热患者 FDG-PET/CT 的回顾性观察研究。
Clin Exp Rheumatol. 2023 Apr;41(4):812-820. doi: 10.55563/clinexprheumatol/uq9p1q. Epub 2023 Apr 18.
6
Prior polymyalgia rheumatica is associated with sonographic vasculitic changes in newly diagnosed patients with giant cell arteritis.先前的巨细胞动脉炎合并多发性肌痛与新诊断的巨细胞动脉炎患者的超声血管炎改变有关。
Rheumatology (Oxford). 2024 May 3;63(6):1523-1527. doi: 10.1093/rheumatology/kead450.
7
Prevalence, characteristics, and outcome of subclinical vasculitis in polymyalgia rheumatica: a retrospective cohort study.风湿性多肌痛中亚临床血管炎的患病率、特征及转归:一项回顾性队列研究
Rheumatology (Oxford). 2024 Dec 1;63(12):3331-3336. doi: 10.1093/rheumatology/keae208.
8
(18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.(18)18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描用于检测风湿性多肌痛患者的大血管血管炎
Rev Esp Med Nucl Imagen Mol. 2015 Sep-Oct;34(5):275-81. doi: 10.1016/j.remn.2015.05.011. Epub 2015 Jul 6.
9
Predictors of positive F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica.预测持续性巨细胞动脉炎患者大血管血管炎 F-FDG PET/CT 扫描阳性的因素。
Semin Arthritis Rheum. 2019 Feb;48(4):720-727. doi: 10.1016/j.semarthrit.2018.05.007. Epub 2018 May 18.
10
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC.FDG-PET/CT(A)成像在大血管血管炎和巨细胞动脉炎中的应用:EANM、SNMMI 和 PET 兴趣小组(PIG)的联合程序建议,并得到 ASNC 的认可。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1250-1269. doi: 10.1007/s00259-018-3973-8. Epub 2018 Apr 11.

引用本文的文献

1
A coding single nucleotide polymorphism in the interleukin-6 receptor enhances IL-6 signalling in CD4 T cells and predicts treatment response to tocilizumab in giant cell arteritis.白细胞介素-6受体中的一个编码单核苷酸多态性增强了CD4 T细胞中的IL-6信号传导,并预测了巨细胞动脉炎患者对托珠单抗的治疗反应。
Ann Rheum Dis. 2025 Aug;84(8):1401-1411. doi: 10.1016/j.ard.2025.01.049. Epub 2025 Feb 24.